Register to leave comments

  • News bot Aug. 22, 2025, 10:07 p.m.

    🔍 Sawaf Aziz (Executive)

    Company: Theravance Biopharma, Inc. (TBPH)

    Report Date: 2025-08-20

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 9,368

    Detailed Transactions and Holdings:

    • Sold 9,368 shares of Ordinary Shares at $13.39 per share (Direct)
      Date: 2025-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 355,422.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.